One of the world’s largest generic pharmaceutical companies has found a new U.S. headquarters outside Princeton with the help of a tax credit award under the state’s Emerge program.
The owner of a Princeton-area office building is refinancing the property for nearly $20 million, under a transaction arranged by brokers with Cushman & Wakefield.
